Government
-
Retrieved from FDA.
Vinay Prasad, controversial FDA leader, to again depart agency
Prasad’s planned departure, expected at the end of April, culminates a tumultuous term in which he reworked vaccine guidelines and was criticized for his office’s stance on several rare disease drugs.
By Jonathan Gardner , Ben Fidler • Updated March 7, 2026 -
Alex Wong via Getty Images
HHS adds cybersecurity guidance to healthcare sector self-assessment tool
Organizations can now use the online platform to test their readiness for digital security crises.
By Eric Geller • March 6, 2026 -
Getty Images
Hospitals urge regulators to halt drugmakers’ expanded 340B data policies
The American Hospital Association argues new policies from Eli Lilly and Novo Nordisk requiring providers to submit more claims data on dispensed 340B drugs is onerous and unlawful.
By Emily Olsen • March 5, 2026 -
Kayla Bartkowski via Getty Images
HHS gets serious on information blocking enforcement
Nearly a decade after Congress banned information blocking, the HHS is making progress cracking down on health IT developers accused of the practice, an agency head said during a Senate subcommittee hearing.
By Sydney Halleman • March 5, 2026 -
Getty Images
Optum Rx, Caremark making ‘significant progress’ in settlement talks with FTC
It’s looking increasingly likely that the UnitedHealth and CVS drug middlemen will also make peace with federal regulators, after Cigna agreed to a sweeping settlement in the insulin lawsuit last month.
By Rebecca Pifer Parduhn • March 5, 2026 -
Spencer Platt via Getty Images
CMS receives record comments on controversial Medicare Advantage payment proposal
The Trump administration wants to keep MA rates flat next year and change how risk adjustment is calculated. Insurers had a lot to say about this, CMS officials shared Tuesday during an event in D.C.
By Rebecca Pifer Parduhn • March 4, 2026 -
Kayla Bartkowski via Getty Images
CMS innovation center remains focused on mandatory models, officials say
CMMI Director Abe Sutton and CMS Administrator Dr. Mehmet Oz outlined how the administration aims to get more providers, especially poor-performing ones, into value-based models at a D.C. event on Tuesday.
By Rebecca Pifer Parduhn • March 4, 2026 -
Getty Images
State Medicaid budgets face $664B cut due to ‘Big Beautiful Bill’: study
Twenty states are projected to experience Medicaid budget reductions of 5% or more from the law’s cuts to the safety-net insurance program, according to the Rand analysis.
By Emily Olsen • March 3, 2026 -
John M. Chase via Getty Images
Education Department urged to broaden ‘professional’ student definition
Professional students will be able to borrow $100,000 more than other graduate students, but a proposed rule would exclude certain healthcare fields, like advanced nursing and physician associates, from the higher cap.
By Ben Unglesbee • March 3, 2026 -
Getty Images
Provider groups push to preserve some IT certification criteria, including AI ‘model cards’
A proposed rule would cull or revise dozens of health IT certification criteria, but providers say regulators should keep some of them to avoid shifting costs or compliance responsibilities back onto clinicians.
By Emily Olsen • March 3, 2026 -
Alamy
CMS threatens Elevance with Medicare Advantage sanctions
Federal regulators are planning to suspend enrollment in Elevance's MA plans at the end of March, in a rare and serious threat to the company’s finances.
By Rebecca Pifer Parduhn • March 3, 2026 -
Alex Wong/Getty Images via Getty Images
Trump administration targets DME suppliers in fraud crackdown
The government plans a six-month moratorium on supplier enrollment in the Medicare program to find ways to stop what it called “longstanding instances of fraud, waste, and abuse” by certain companies.
By Susan Kelly • Feb. 27, 2026 -
Rebecca Pifer/Healthcare Dive
How PBM reforms could push drugmakers into the pricing spotlight
The Consolidated Appropriations Act’s landmark PBM overhaul removes financial incentives tied to pharma list prices, potentially leaving drugmakers to defend their own practices.
By Alivia Kaylor • Feb. 27, 2026 -
Alex Wong/Getty Images via Getty Images
Trump administration halts over $259M in Medicaid funds to Minnesota
The funds would be a fraction of the $11.8 billion in Medicaid funding the state receives from the federal government. The Trump administration said the action was part of a broader crackdown on fraud in federal healthcare programs.
By Sydney Halleman • Feb. 26, 2026 -
Andrew Harnik via Getty Images
Trump’s State of the Union trumpets healthcare greatest hits, but no new policies
In his lengthy address Tuesday night, the president touted his efforts to make drugs and insurance more affordable but steered clear of hot-button issues like vaccine access and the GOP’s Medicaid cuts.
By Rebecca Pifer Parduhn • Feb. 25, 2026 -
Mark Wilson via Getty Images
Veradigm avoids enforcement action in SEC probe
The investigation began after the health IT company failed to comply with financial reporting requirements, which led to its delisting from the Nasdaq in early 2024.
By Emily Olsen • Feb. 25, 2026 -
Elijah Nouvelage via Getty Images
15 states sue HHS over changes to childhood vaccine schedule
The lawsuit seeks to reverse the abrupt overhaul of the U.S. immunization schedule as well as the federal government’s allegedly unlawful reformation of a key vaccine panel.
By Delilah Alvarado • Feb. 25, 2026 -
Getty Images
Medicare Advantage growth decelerates as insurers shed members for 2026
A Healthcare Dive analysis lays out just how drastically insurers retrenched their MA businesses for 2026, with UnitedHealthcare, CVS and Elevance discarding hundreds of thousands of members.
By Rebecca Pifer Parduhn • Feb. 24, 2026 -
Getty Images
GOP’s ‘Big Beautiful Bill’ erases 12 years of solvency for Medicare trust fund: CBO
Congressional scorekeepers expect the Hospital Insurance trust fund to run dry more than a decade earlier than they previously expected, after Republicans’ megabill slashed the revenues it receives from taxes.
By Rebecca Pifer Parduhn • Feb. 24, 2026 -
Julia Rendleman via Getty Images
Worker did not plausibly argue obesity was a disability, 1st Circuit finds
In a lawsuit filed against Cigna for refusing to cover weight loss medication, a Maine worker described the condition and its impact too generally, the appeals court said.
By Emilie Shumway • Feb. 23, 2026 -
The image by Sixflashphoto is licensed under CC BY-SA 4.0
Justice Department sues OhioHealth over alleged anticompetitive insurer contracts
The DOJ filed a lawsuit last week accusing OhioHealth of leveraging its market power to force insurers to include its providers in their networks.
By Sydney Halleman • Feb. 23, 2026 -
Kevin Dietsch via Getty Images
Trump sets fresh 10% global tariff — and plans to increase further
The new duties will go into effect Feb. 24, although the president has since signaled he will raise the rate to 15%. Medical supplies were not included in a list of exempted items.
By Antone Gonsalves , Phil Neuffer • Updated Feb. 21, 2026 -
Chip Somodevilla via Getty Images
Supreme Court invalidates Trump tariffs based on emergency powers
In a 6-3 decision, the court rejected President Trump's claim that a 1977 law gave him the authority to impose broad tariffs globally.
By Antone Gonsalves • Feb. 20, 2026 -
Maddie Meyer via Getty Images
FDA reverses course on Moderna’s flu vaccine
Moderna said the agency agreed to move forward and review its application for the mRNA-based shot.
By Delilah Alvarado • Feb. 18, 2026 -
Getty Images
Federal judge strikes down FTC rule expanding premerger reporting requirements
The regulation required firms to provide more details ahead of mergers, likely chilling dealmaking. The Federal Trade Commission could appeal the ruling.
By Emily Olsen • Feb. 18, 2026
